Collegium Pharmaceutical (COLL) EPS (Basic) (QoQ) (2014 - 2026)
Collegium Pharmaceutical (COLL) EPS (Basic) (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Collegium Pharmaceutical | 892.02 Mn | 742.71 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -202.63% |
| Mar 31, 2026 | -15.56% |
| Dec 31, 2025 | -46.39% |
| Sep 30, 2025 | 164.92% |
| Jun 30, 2025 | 395.52% |
| Mar 31, 2025 | -80.43% |
| Dec 31, 2024 | 34.23% |
| Sep 30, 2024 | -52.13% |
| Jun 30, 2024 | -29.49% |
| Mar 31, 2024 | -9.44% |
| Dec 31, 2023 | 54.81% |
| Sep 30, 2023 | 62.77% |
| Jun 30, 2023 | 173.99% |
| Mar 31, 2023 | -138.61% |
| Dec 31, 2022 | -1,685.95% |
| Sep 30, 2022 | 108.79% |
| Jun 30, 2022 | 60.66% |
| Mar 31, 2022 | 45.84% |
| Dec 31, 2021 | -415.03% |
| Sep 30, 2021 | -89.15% |